Companies: 10,795·Total market cap: $144.5T
MorphoSys AG

MorphoSys AG

MORNASDAQHealthcare
$18.96
+$0.45(+2.43%)
Market Cap$2.9B
P/E Ratio—
52W High$19.5
52W Low$4.185
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

MorphoSys AG (MOR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001340243 · MOR · NASDAQ · as of Jun 8, 2026

Filing snapshot

650
Total Filings
15-12G
Latest Form
2024-10-17
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001340243 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2024-03-13
Fiscal Year End
Mar 13, 2024
Accession No.
0001628280-24-010887
Primary Document
mor-20231231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001340243 · Accession 0001628280-24-010887

Latest Key Filings

6-KQuarterly Report
6-K
2024-08-29
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
FORM 15-12G
2024-10-17
View
SC 13D/ASC 13D/A
SC 13D/A
2024-10-17
View
S-8 POSS-8 POS
S-8 POS
2024-10-04
View
S-8 POSS-8 POS
S-8 POS
2024-10-04
View
S-8 POSS-8 POS
S-8 POS
2024-10-04
View
S-8 POSS-8 POS
S-8 POS
2024-10-04
View
S-8 POSS-8 POS
S-8 POS
2024-10-04
View
S-8 POSS-8 POS
S-8 POS
2024-10-04
View
S-8 POSS-8 POS
S-8 POS
2024-10-04
View
POSASRPOSASR
POSASR
2024-10-04
View
6-KCurrent Report (Foreign Issuer)
6-K
2024-08-29
View
6-KCurrent Report (Foreign Issuer)
6-K
2024-08-27
View
SC 13D/ASC 13D/A
SC 13D/A
2024-08-15
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2024-08-13
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2024-08-07
View
Showing 1–15 of 650 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001340243  |  Exchange: NASDAQ · Healthcare

MorphoSys AG (NASDAQ: MOR) has submitted 650 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001340243, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is MorphoSys AG's most comprehensive regulatory disclosure. The most recent MorphoSys AG 10-K was filed on 2024-03-13 for fiscal year ending 2024. Historical MOR 10-K annual reports are available from 2005 through 2024.

Investors researching MorphoSys AG SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
SWTX SEC Filings →MORF SEC Filings →KDNY SEC Filings →MYOV SEC Filings →PRVB SEC Filings →LBPH SEC Filings →DICE SEC Filings →BLU SEC Filings →
→ MOR Financials→ MOR Earnings→ MOR Insider Trades

Frequently Asked Questions

MOR SEC Filings · 8 questions

MorphoSys AG (MOR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 650 filings and access original documents at no cost. MorphoSys AG's CIK is 0001340243.

MOR SEC filingsMorphoSys AG SEC documentsfind MOR 10-K